Technology Meets Medical: Using Artificial Intelligence with Parkinson's Disease

Artificial intelligence may be a smart move as research is always evolving, but it still has a downside—the high cost of research.

Using artificial intelligence on research costs a lot of money but decreases the time of work. With no guarantee of getting new information and details until the end of the research, it is a big risk for pharmaceutical companies and scientists to begin a study even with the proper planning.